Wu Daiqian, Hu Qian, Wang Yuqing, Jin Mengying, Tao Ziqi, Wan Jing
Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Front Cardiovasc Med. 2022 Apr 14;9:833642. doi: 10.3389/fcvm.2022.833642. eCollection 2022.
Ferroptosis is a novel form of programmed iron-dependent cell death. The ferroptosis-related genes (FRGs) have been recognized as biomarkers for cancers. Increasing evidence has indicated that ferroptosis is involved in the process of atherosclerosis. However, the potential FRGs used for the diagnosis, prognosis and therapy for atherosclerosis are still unclear. We aimed to identify the ferroptosis-related differentially expressed genes (DEGs) of atherosclerosis. We downloaded the mRNA-sequencing data of patients with atherosclerosis from the Gene Expression Omnibus (GEO) database. HMOX1 was identified as an essential ferroptosis-related DEG by bioinformatic analysis of the GSE28829 and GSE43292 datasets. The pro-ferroptotic effect of HMOX1 was validated through cell experiments. Then we conducted a single-gene analysis of HMOX1 and found that high-expression of HMOX1 in atherosclerotic plaques was accompanied by matrix metalloproteinases (MMPs) producing and M0 macrophages infiltration. Taken together, our present study suggested HMOX1 as a potential diagnostic biomarker for atherosclerosis and provided more evidence about the vital role of ferroptosis in atherosclerosis progression.
铁死亡是一种新的程序性铁依赖性细胞死亡形式。铁死亡相关基因(FRGs)已被公认为癌症的生物标志物。越来越多的证据表明,铁死亡参与动脉粥样硬化的过程。然而,用于动脉粥样硬化诊断、预后和治疗的潜在FRGs仍不清楚。我们旨在鉴定动脉粥样硬化的铁死亡相关差异表达基因(DEGs)。我们从基因表达综合数据库(GEO)下载了动脉粥样硬化患者的mRNA测序数据。通过对GSE28829和GSE43292数据集的生物信息学分析,HMOX1被鉴定为一个重要的铁死亡相关DEG。通过细胞实验验证了HMOX1的促铁死亡作用。然后我们对HMOX1进行了单基因分析,发现动脉粥样硬化斑块中HMOX1的高表达伴随着基质金属蛋白酶(MMPs)的产生和M0巨噬细胞的浸润。综上所述,我们目前的研究表明HMOX1作为动脉粥样硬化的潜在诊断生物标志物,并为铁死亡在动脉粥样硬化进展中的重要作用提供了更多证据。